LncRNA RP11-84E24.3通过TFAP2C激活SNAI1驱动胶质瘤细胞上皮-间质转化与致瘤
该研究探讨lncRNA RP11-84E24.3在胶质瘤发生发展中的作用及分子机制。研究发现该lncRNA在胶质瘤组织和细胞系中上调,过表达可促进增殖、迁移、侵袭并抑制凋亡,伴随E-cadherin降低及N-cadherin、Vimentin升高。机制上,RP11-84E24.3直接靶向TFAP2C蛋白,增加SNAI1表达,敲低TFAP2C或SNAI1可逆转其效应,沉默该lncRNA抑制体内成瘤。
要点
- RP11-84E24.3在胶质瘤中高表达,促进细胞增殖、迁移和侵袭。
- 该lncRNA通过结合TFAP2C上调SNAI1,诱导上皮-间质转化。
- 沉默RP11-84E24.3可抑制胶质瘤细胞体内成瘤。
核心结论
- LncRNA RP11-84E24.3通过与TFAP2C蛋白形成复合物增加SNAI1表达,促进胶质瘤细胞上皮-间质转化和肿瘤形成。
研究设计与样本
- 研究检测了胶质瘤患者样本和胶质瘤细胞系中差异表达的lncRNA,并采用功能获得和缺失实验、EdU掺入、流式细胞术、伤口愈合和Transwell侵袭实验评估细胞表型。
- 采用Western blot检测上皮-间质转化相关蛋白,并通过RNA pull-down、ChIP和荧光素酶报告基因实验确认lncRNA RP11-84E24.3、TFAP2C与SNAI1的相互作用。
- 体内实验通过沉默lncRNA RP11-84E24.3评估胶质瘤细胞成瘤能力。
主要发现
- LncRNA RP11-84E24.3在胶质瘤组织和细胞系中均上调。
- 过表达RP11-84E24.3增强胶质瘤细胞增殖、迁移和侵袭,减少凋亡,并伴随E-cadherin表达降低及N-cadherin和Vimentin表达升高。
- RP11-84E24.3直接靶向TFAP2C蛋白,导致SNAI1表达增加。
- 敲低TFAP2C或SNAI1可逆转RP11-84E24.3过表达的效应。
- 沉默RP11-84E24.3抑制胶质瘤细胞体内成瘤。
临床怎么用
- RP11-84E24.3可能作为胶质瘤潜在的分子标志物或治疗靶点,但需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Long noncoding RNAs (LncRNAs) are essential epigenetic regulators with critical roles in tumor initiation and malignant progression; however, the mechanism by which aberrantly expressed lncRNA RP11-84E24.3 regulates the pathogenesis of glioma is not fully understood. Here, we investigate the function of lncRNA RP11-84E24.3 in glioma onset and progression as well as identify a molecular pathway regulated by this lncRNA. METHODS: Differentially expressed lncRNAs related to glioma were identified. The aberrant expression of lncRNA RP11-84E24.3 was verified in samples from patients with glioma as well as glioma cell lines. The role of lncRNA RP11-8424.3 in proliferation, apoptosis, migration, and invasion was assessed using gain- and loss-of function approaches, EdU incorporation, flow cytometry, wound healing and Transwell invasion assays. Western blot analysis was utilized to examine the expression of proteins associated with epithelial-to-mesenchymal transition (EMT). The interaction between lncRNA RP11-84E24.3, TFAP2C and SNAI1 was confirmed using RNA pull-down, ChIP and luciferase reporter assays. RESULTS: LncRNA RP11-84E24.3 was up-regulated in both glioma tissues and cell lines. LncRNA RP11-84E24.3 overexpression enhanced the proliferation, migration and invasion of glioma cells while reducing apoptosis. This was associated with a decrease in E-cadherin expression and an increase in N-cadherin and Vimentin expression. LncRNA RP11-84E24.3 directly targeted TFAP2C protein, resulting in increased SNAI1 expression. Knockdown of TFAP2C or SNAI1 reversed the effects of lncRNA RP11-84E24.3 overexpression, while silencing lncRNA RP11-84E24.3 inhibited tumor formation of glioma cells in vivo. CONCLUSIONS: LncRNA RP11-84E24.3 increased SNAI1 expression by forming a complex with TFAP2C protein, promoting EMT in glioma cells and tumor formation.
引用
- Chang L, Wang J, Zhou F, et al. LncRNA RP11-84E24.3 drives tumorigenesis and epithelial-to-mesenchymal transition of glioma cells by promoting TFAP2C-mediated activation of SNAI1. J Neurooncol. 2020. PMID: 33128099. doi:10.1007/s11060-020-03624-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。